期刊文献+

循环肿瘤细胞在乳腺癌患者中的临床意义 被引量:2

原文传递
导出
摘要 乳腺癌在肿瘤发展早期就可远处播散,乳腺癌术后复发和转移是影响预后的主要因素,在外周血中发现肿瘤细胞即是重要证据,因而提出了循环肿瘤细胞(circulating tumor cell,CTC)的概念。检测乳腺癌CTC有助于准确的判断预后,并为及时评判和监测治疗效果提供依据,有利于患者的个体化治疗,具有重要的临床意义。
出处 《华西医学》 CAS 2010年第10期1927-1929,共3页 West China Medical Journal
  • 相关文献

参考文献25

  • 1宁连胜,方志忻.现代乳腺疾病治疗学[M].2版.北京:人民卫生出版社,2007:27-29.
  • 2Husemann Y, Geigl JB, Schubert F, et al. Systemic spread is an early step in breast cancer [J]. CancerCell, 2008,13 (1):58- 68.
  • 3Racila E, Euhus D, Weiss AJ, et al. Detection and characterization of carcinoma ceils in the blood[J]. Proc Natl Acad Sci USA, 1998,95 (8):4589-4594.
  • 4Gilbey AM, Burnett D, Coleman RE, et al. The detection of circulating cancer cells in blood[J]. J Clin Pathol, 2004, 57: 903-911.
  • 5陈艳(综述),王熙才(审校),伍治平(审校).乳腺癌循环肿瘤细胞[J].国际肿瘤学杂志,2008,35(2):122-124. 被引量:1
  • 6Kirk S J, Cooper GG, Hoper M, et al. The prognostic signifycancer of marrow micrometastases in women with early breast cancer[J]. Eur J Surg Oncol, 1990, 16: 481-485.
  • 7Osborne M, Rosen P. Detection and management of bone marrow micrometastases in breast cancer[J]. Oncology, 1994, 8:25-36.
  • 8Sloane JP, Ormerod MG, Neville AM. Potential pathological application of immunocytoehemical methods to the [VAC13] detection of micrometastases [J]. Cancer Res, 1980, 40 (8) 3079 -3082.
  • 9Irene G, Nicolas S, John N, et al. In vivo flow cytometry: A new method for enumerating circulating cancer cells[J]. Cancer Res, 2004,64:5044- 5047.
  • 10Lee GS, Ryu KS, Rha JG, et al. Multiparametric flow cytometric analysis in a breast cancer cell line (MCF-7) [J]. J Obstet Gynaecol Res, 2002, 28(3) : 141- 148.

二级参考文献195

共引文献53

同被引文献30

  • 1Ashworth TR. A case of cancer in which cells similar to those in the tumors were seen in the blood after death[J]. Aust Med J, 1869,14:146.
  • 2Paget S. Distribution of secondary growths in cancer of the breast [J]. Lancet, 1889,1:571.
  • 3Jiang Z F,Cristo fanilli M,Shao Z M,et al. Circulating tumor cells predict progression-free and overall survival in Chinese patients with metastatic breast cancer, HER2-positive or triple-negative (CBCSG004) : a multicenter, double-blind, prospective trial [J]. Ann Oncol,2013.
  • 4von Minekwitz G, Untch M, Blohmer JU, et al. De nition and im- pact of pathologiccomplete response on prognosis after neoadju- vant chemotherapy in variousintrinsie breast cancer subtypes[J]. J Clin Oncol, 2012,30 : 1796.
  • 5Aliki Stathopoulou, Anna Gizi, Maria Perraki, et al. Real-Time Quantification of CK-19 mRNA-Positive Ceils in Peripheral Blood of Breast Cancer Patients Using the Lightcycler System[J]. Clini- cal Cancer Research, 2003,9 : 5145.
  • 6De Giorgi,et al. Circulating Tumor Cells and Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Out- come Prediction in Metastatic Breast Cancer[J]. Clin Oncol, 2009, 27(20) :3303.
  • 7Ramadan A, Harouakal, et al. Circulating Tumor Cell Enrich- ment Based on Physieal Properties[J]. Journal Laboratory Auto- mation,2013,18(6) :455.
  • 8Caitlin D May1, Nathalie Sphyrisl, et al. Epithelial-mesenchymal transition and cancer stem cells: a dangerously dynamic duo in breast[J]. J Breast Cancer Research, 2011,13 : 202.
  • 9ousden KH, Lane DP. P53 in health and disease[J]. Nat Rev MolCell Bicol, 2007,8 ( 11 ) : 275.
  • 10Shirley S H,Rundhaug J E,T ian J,et al. T ranscript iona 1 regulation of estrogen recep tor-a by p53 in hum an breast cancer cells[J]. Cancer Res,2009,69(8) :3405.

引证文献2

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部